Taro Pharmaceutical Industries Shares Close in on 52-Week Low - Market Mover
The shares closed 1.5% above its 52-week low of $43.29, with trading volume higher than its 30 day average
Feb 07, 2022 by Kwhen Finance Editors
Taro Pharmaceutical Industries (TARO) shares closed today at 1.5% above its 52 week low of $43.29, giving the company a market cap of $1B. The stock is currently down 11.7% year-to-date, down 41.3% over the past 12 months, and down 52.2% over the past five years. This week, the Dow Jones Industrial Average rose 1.1%, and the S&P 500 rose 1.5%.
Trading Activity
- Trading volume this week was 17.3% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.5.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Taro Pharmaceutical Industries | -0.7 | -11.7 | -41.3 | -44.4 | 2.7 |
| Dow Jones Industrial Average | 0.0 | -3.4 | 14.6 | -4.9 | 16.7 |
| S&P 500 Index | -0.3 | -5.5 | 17.3 | -6.4 | 22.5 |
| Health Care | -0.2 | -7.2 | 10.8 | -7.7 | 18.6 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 26640.3%
- The company's stock price performance over the past 12 months lags the peer average by -431.7%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Taro Pharmaceutical Industries | TARO | 0 | -11.7 | -41.3 | -44.4 | 2.7 |
| Peer Avg | N/A | 17.2 | -0.0 | 12.4 | -13.1 | 94.6 |
| Johnson & Johnson | JNJ | 25.3 | 0.3 | 7.0 | -3.6 | 15.3 |
| Pfizer Inc. | PFE | 15.5 | -9.6 | 57.2 | -12.9 | 65.5 |
| Novartis AG - ADR | NVS | 4.4 | -1.4 | -0.9 | -8.6 | 9.7 |
| Merck & Co Inc | MRK | 27.6 | 2.5 | 7.4 | -12.9 | 428.8 |
| Glaxosmithkline plc - ADR | GSK | 17.3 | 1.6 | 34.4 | -4.4 | 38.8 |
| Teva- Pharmaceutical Industries Ltd. - ADR | TEVA | 12.9 | 6.2 | -30.5 | -36.3 | 9.6 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: